Literature DB >> 7616949

Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1993-1994.

.   

Abstract

Before effective vaccines were available, Haemophilus influenzae type b (Hib) was the most common cause of bacterial meningitis among children in the United States. Since the introduction of Hib conjugate vaccines in 1988, the incidence of invasive Hib infection has declined by at least 95% among infants and children (1,2). As part of the Childhood Immunization Initiative (CII), the Public Health Service has included Hib disease among children aged < 5 years as one of the vaccine-preventable diseases targeted for elimination in the United States by 1996 (3). This report summarizes provisional data about invasive Hi disease during 1993-1994 based on information from three surveillance systems: the National Notifiable Diseases Surveillance System (NNDSS), the National Bacterial Meningitis and Bacteremia Reporting System (NBMBRS), and a multistate laboratory-based surveillance system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7616949

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  4 in total

Review 1.  Antigenic diversity and gene polymorphisms in Haemophilus influenzae.

Authors:  J R Gilsdorf
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

2.  Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine.

Authors:  Birgit Simell; Anu Nurkka; Nina Ekström; Noga Givon-Lavi; Helena Käyhty; Ron Dagan
Journal:  Clin Vaccine Immunol       Date:  2012-08-08

3.  Cost-benefit analysis of Haemophilus influenzae type b vaccination in children in Spain.

Authors:  F J Jiménez; P Guallar-Castillón; C Rubio Terrés; E Guallar
Journal:  Pharmacoeconomics       Date:  1999-01       Impact factor: 4.981

4.  Immunogenicity and reactogenicity of HbOC vaccine administered simultaneously with acellular pertussis vaccine (DTaP) into either arms or thighs of infants.

Authors:  H J Schmitt; C H Wirsing von König; F Zepp; J Huff; K Jahn; P Schmidtke; C Meyer; P Habermehl; R Uhlenbusch; P Angersbach
Journal:  Infection       Date:  1997 Sep-Oct       Impact factor: 3.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.